Live Breaking News & Updates on Pharmaceutical Excellence

Stay updated with breaking news from Pharmaceutical excellence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Strong organic growth in core markets underscores resilience of Dermapharm Holding SE's corporate strategy

EQS-News: Dermapharm Holding SE

/ Key word: Quarterly / Interim Statement/Quarter Results

Strong organic growth in core markets underscores resilience of Dermapharm Holding SE s. ....

United States , Sachsen Anhalt , Mecklenburg Vorpommern , Pharm Gmb , Hans Georg Feldmeier , Britta Hamberger , Board Of Management Dermapharm Holding , Arkopharma Group , Dermapharm Holding , Wellster Healthtech Group Gmb , Dermapharm Holding Se , Investor Relations Corporate Communications , Dermapharm Group , Wellster Healthtech Group Gmbh , Pharmaceutical Excellence ,

Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges

EQS-News: Dermapharm Holding SE

/ Key word: Annual Results/Annual Report

Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges. ....

Sachsen Anhalt , United States , Hans Georg Feldmeier , Britta Hamberger , Dermapharm Holding Se , Arkopharma Group , Dermapharm Holding , Board Of Management Dermapharm Holding , Meeting Of Dermapharm Holding , French Arkopharma Group , Investor Relations Corporate Communications , Annual Report , Middle East , General Meeting , Annual General Meeting , Supervisory Board , Pharmaceutical Excellence ,

Sofgen Pharmaceuticals

Sofgen Pharmaceuticals is an integrated CDMO that offers end-to-end solutions, from development throughout delivery in innovative Softgel technologies for pharma and healthcare companies interested in launching novel products within North America and other high regulated markets. ....

United States , Sofgen Pharmaceuticals , North America , Pharmaceutical Excellence , West Palm Beach Florida , Itamins Amp Premixes ,

Dermapharm Holding SE builds on success in Q3 2023

EQS-News: Dermapharm Holding SE / Key word(s): 9 Month figures/Quarterly / Interim StatementDermapharm Holding SE builds on success in Q3 2023 15.11.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Dermapharm Holding SE builds on success in Q3 2023   Consolidated r. ....

Sachsen Anhalt , United States , Britta Hamberger , Hans Georg Feldmeier , Arkopharma Group , Pharmaceuticals Gesetz , Dermapharm Holding Se Key , Board Of Management Dermapharm Holding , Dermapharm Holding , Investor Relations Corporate Communications , Dermapharm Holding Se , Distribution Services , Interim Statement , German Act , More Safety , Pharmaceutical Excellence , Corporate News , Regulatory Announcements ,

Move from 'Volume' to 'Value': Draft National Pharma Policy Plans Big Boost to AI, Blockchain & Patents

According to the document, the top five focus areas described as ‘pillars’ are fostering global pharmaceutical leadership, promoting self-reliance, advancing health equity and accessibility, enhancing regulatory efficiency in the Indian pharmaceutical sector and attracting investments ....

Vasudhaiva Kutumbakam , Mansukh Mandaviya , Atma Nirbhar Bharat , Department Of Pharmaceuticals On , National Pharmaceuticals , Health Access For Everyone , Department Of Pharmaceuticals , Indian Patent Office , National Pharmaceutical , National Pharmaceutical Policy , Amrit Kaal , Indian Standards , Health Access , Pharmaceutical Excellence , Intellectual Property , Prime Minister Narendra Modi , National Pharmaceuticals Policy , Vasudhaiva Kutumbakam , Artificial Intelligence ,